Year of Establishment
1935
Company Introduction
Polpharma API is a part of Polish leading multinational pharmaceutical group trusted by millions of patients and business partners for almost 90 years.
Polpharma API. Thanks to over 70 years of experience in process development, scale-up and cGMP manufacturing, we support both emerging and established pharmaceutical customers in the development and commercialization of their small molecule API clinical candidates. At our FDA-approved plant located in Central Europe, we provide end-to-end solutions from API development to scale-up allowing smooth process transfer for commercial-scale manufacturing capabilities, with world-class regulatory support. Our strong R&D management team, experienced in the development of chemical processes and complex projects, provides a wide range of solutions to our customers, applying a variety of chemical reactions and conditions, including cryogenic, High Pressure, strong base reactions, and tailor-made particle size distribution modifications. At Polpharma quality comes first. Regular FDA audits prove our reliability and credibility towards business partners around the world. Our team of highly qualified, skilled and enthusiastic experts combined with state-of-the-art equipment and facilities provides our partners with an outstanding customer experience.
Polpharma API. Your European CDMO partner.
Main Competitive Advantages
Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service,
Website
https://www.api.polpharma.com/
Other Competitive Advantages
✅ 70 years of experience in API business
✅ Generics and CDMO
From development to commercial
✅ Full value chain:
R&D, Production, Supply Chain, PMO
✅ European location
R&D and 2 manufacturing plants
✅ Agile organisation
Fast decising making, top execution
✅ Project management excellence
✅ Global market presence
Milestone
At Polpharma API, we specialize in:
✅ HP API OEB 5&6
✅ High-potency payloads: Designed for maximum efficacy while minimizing off-target effects.
✅ Advanced linker technologies: Ensuring stability in circulation and precise release at the target site.
✅ Customizable solutions: Tailored to meet the unique needs of your ADC development pipeline.
✅ Cryogenic reactions